Adicet Bio, Inc. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
Adicet Bio, Inc. (ACET) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $1.35 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2022-11-08
- Adicet Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-09-30 was $1.35M.
- Adicet Bio, Inc. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2022-03-31 was $1.11M.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month |
|---|---|
| 2022-09-30 | $1.35M 10-Q · filed 2022-11-08 |
| 2022-03-31 | $1.11M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |